Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Participant- and Investigator Blind, Double Dummy, Placebo- and Comparator-controlled, Single Ascending Dose and Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Different Modes of (S) Ketamine Administration in Healthy Participants

To see complete record on, please visit this link

Id: NCT03808259

Organisation Name: Janssen Research & Development, LLC

Overal Status: Completed

Start Date: December 20, 2018

Last Update: September 12, 2019

Lead Sponsor: Janssen Research & Development, LLC

Brief Summary: The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of different modes of (S) ketamine administration in healthy participants.

  • Healthy

Total execution time in seconds: 0.52326703071594